|
Stockpickr.com
|
1
|
Mannkind
|
Jul 11, 2012 11:52AM
|
|
Re: Will This Large Biotech Pop Experience Analyst Backlash?
|
1
|
Mannkind
|
Aug 22, 2013 03:24PM
|
|
3 Events Biotech Investors Need to Watch in 2013
|
1
|
Mannkind
|
Feb 13, 2013 04:18PM
|
|
Remember this?
|
1
|
Mannkind
|
Jan 14, 2013 09:58AM
|
|
Re: MannKind announces $160M debt financing
|
1
|
Mannkind
|
Jul 01, 2013 12:51PM
|
|
Re: The Ideal Diabetes Therapy: What Will It Look Like?How Close Are We?
|
1
|
Mannkind
|
Oct 29, 2012 12:03PM
|
|
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
|
1
|
Mannkind
|
Feb 18, 2013 09:09AM
|
|
Re: Drugmaker Eli Lilly to cut 1,000 U.S. sales jobs
|
1
|
Mannkind
|
Apr 12, 2013 03:04PM
|
|
Re: What's your MNKD strategy? BO or PA -- pre or post?
|
1
|
Mannkind
|
Jul 29, 2013 12:11PM
|
|
Here's What This $30 Billion Pension Fund Has Been Buying
|
1
|
Mannkind
|
Jul 27, 2013 09:18AM
|
|
Re: CREW Calls for DOJ Investigation Into Short-Seller Shkreli
|
1
|
Mannkind
|
Jul 09, 2012 06:53PM
|
|
Re: Michael Higgins on Biotech Names with Major Market Potential
|
1
|
Mannkind
|
Dec 21, 2012 09:16AM
|
|
Re: Time goes fast
|
1
|
Mannkind
|
Jul 18, 2012 01:25PM
|
|
Re: ADA 2012: Early Use of Insulin of No Benefit, Though No Harm:
|
1
|
Mannkind
|
Jun 12, 2012 09:43AM
|
|
Re: Treating T2DM with Early Insulin Therapy
|
1
|
Mannkind
|
Jan 04, 2013 06:04PM
|
|
3 Biotech Catalysts Primed To Be Successful In Q3
|
1
|
Mannkind
|
Jul 23, 2013 02:23PM
|
|
Alexza's Adasuve May Not Be Ready For FDA Approval
|
1
|
Mannkind
|
Dec 11, 2012 04:50PM
|
|
MannKind and Ariad Pharma Under Review: Biotech Companies Receive Drug Approvals
|
1
|
Mannkind
|
Feb 22, 2013 09:41AM
|
|
MannKind Corporation to Hold 2012 Fourth Quarter...
|
1
|
Mannkind
|
Feb 04, 2013 05:24PM
|
|
Re: Why is MNKD not presenting at the June 21st ADA meeting?
|
1
|
Mannkind
|
Jun 09, 2013 09:01PM
|
